Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
Trump’s ‘Debanking’ Order Raises Questions for Lenders Days after accusing JPMorgan Chase and Bank of America of discriminating against him and other conservatives, President Donald...
Tech Groups Battling AI Regulation in CA Tech industry groups including the Business Software Alliance, the Consumer Technology Association and the Chamber of Progress are stepping up their lobbying...
Seven years after the U.S. Supreme Court struck down the Professional and Amateur Sports Protection Act , states continue to wrestle with how best to regulate sports betting, an industry that now generates...
SC Proposes Rate Cuts for Some Credit Property Insurance South Carolina’s Department of Insurance plans to cut the rates for some credit property insurance, which lenders sometimes require to protect...
States Eying Higher Electricity Rates for Data Centers At least a dozen states are considering ways to make data centers pay more for their power, with evidence mounting that data center demand is driving...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
Telemedicine Still ‘Critical Focus’ for State Lawmakers: This year states passed at least 176 bills that adjust existing laws to accommodate the higher demand for telehealth services since the Covid-19 pandemic. That total roughly equals the 171 bills enacted in 2023, indicating that “telehealth remains a critical focus of state legislative efforts, showcasing its growing role in the healthcare landscape,” according to the Center for Connected Health Policy, a national nonprofit that advocates for state and federal telehealth policies. (PLURIBUS NEWS, CENTER FOR CONNECTED HEALTH POLICY)
NY Gov Signs EpiPen Insurance Bill: New York Gov. Kathy Hochul (D) signed a bill (SB 7114) that will require health insurers to cover EpiPens, used to treat severe allergic reactions. The measure also caps consumer out-of-pocket costs for the devices at $100. Some reports indicate the cost of EpiPens has risen 600% since 2007, according to Hochul’s office. (STATE OF POLITICS, LEXISNEXIS STATE NET)
—Compiled by SNCJ Managing Editor KOREY CLARK